Skip to Main Content

Paper Details

Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status.
Acta Neuropathol Commun
0
2023
H3, ID2, IDH, MYCN, TP53, diffuse high-grade glioma
Author NameAffiliation
Felix SahmInstitute of Pathology, University Hospital Heidelberg
Felix SahmClinical Cooperation Unit Neuropathology, German Cancer Research Center DKFZ)
Felix SahmInstitute of Pathology, University Hospital Heidelberg
Felix SahmClinical Cooperation Unit Neuropathology, German Cancer Research Center DKFZ)
Pascale Varlet
Pascale VarletInstitute of Psychiatry and Neuroscience of Paris (IPNP), Universite Paris Cite, INSERM U1266
Pascale Varlet
Pascale VarletInstitute of Psychiatry and Neuroscience of Paris (IPNP), Universite Paris Cite, INSERM U1266
  • 1 - 8

Datasets

Release 1.2